Impact of body mass index in Korean patients with renal cell carcinoma

被引：0
|
作者：
Hyun Hwan Sung
Seong Soo Jeon
Seo Yong Park
Byong Chang Jeong
Seong Il Seo
Hyun Moo Lee
Han-Yong Choi
机构：
[1] Sungkyunkwan University School of Medicine,Department of Urology, Samsung Medical Center
来源：
Cancer Causes & Control | 2012年 / 23卷
关键词：
Body mass index; Prognosis; Renal cell carcinoma; Underweight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 511
页数：6
相关论文
共 50 条
  • [41] The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal Carcinoma
    Greene, John
    Wang, Zhe
    Harris, Benjamin H. L.
    Dodwell, David
    Lord, Simon R.
    CANCER CONTROL, 2025, 32
  • [42] Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma
    Bergerot, Paulo Gustavo
    Bergerot, Cristiane Decat
    Philip, Errol J.
    Meza, Luis
    Dizman, Nazli
    Hsu, JoAnn
    Pal, Sumanta Kumar
    KIDNEY CANCER, 2019, 3 (01) : 63 - 70
  • [43] Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
    Antoun, S.
    Baracos, V. E.
    Birdsell, L.
    Escudier, B.
    Sawyer, M. B.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1594 - 1598
  • [44] THE ASSOCIATION BETWEEN BODY MASS INDEX (BMI), MORPHOLOGIC TYPE AND SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA (RCC) IN LATVIA
    Baltina, Dace
    Vaivode, Ieva
    Lietuvietis, Vilnis
    Sperga, Maris
    Ulase, Dita
    Vitenberga, Zane
    Donina, Simona
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 64 - 64
  • [45] Body mass index and survival of patients with metastastic renal cell carcinoma: Data from the German prospective RCC registry
    Mueller, Lothar
    Goebell, Peter J.
    Von Verschuer, Ulla
    Hurtz, Hans-Juergen
    Franzem, Melanie
    Vogt, Michele
    Marschner, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [46] Prognostic significance of body mass index in patients with metastatic renal cell carcinoma treated with first-line therapies
    Sato, K.
    Takemura, K.
    Oki, R.
    Urasaki, T.
    Yoneoka, Y.
    Fujiwara, R.
    Yasuda, Y.
    Oguchi, T.
    Numao, N.
    Yamamoto, S.
    Yonese, J.
    Yuasa, T.
    EUROPEAN UROLOGY, 2024, 85 : S181 - S182
  • [47] Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies
    Sato, Keigo
    Takemura, Kosuke
    Oki, Ryosuke
    Urasaki, Tetsuya
    Yoneoka, Yusuke
    Fujiwara, Ryo
    Yasuda, Yosuke
    Oguchi, Tomohiko
    Numao, Noboru
    Yamamoto, Shinya
    Yonese, Junji
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (04) : 269e1 - 269e6
  • [48] Do patients with a higher body mass index have a greater risk of advanced-stage renal cell carcinoma?
    Schips, L
    Zigeuner, R
    Lipsky, K
    Quehenberger, F
    Salfellner, M
    Winkler, S
    Pummer, K
    Hubmer, G
    UROLOGY, 2003, 62 (03) : 437 - 441
  • [49] Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis
    Choi, Yuni
    Park, Bumsoo
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han Yong
    Adami, Hans-Olov
    Lee, Jung Eun
    Lee, Hyun Moo
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (03) : 625 - 634
  • [50] The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy
    Haferkamp, Axel
    Pritsch, Maria
    Bedke, Jens
    Wagener, Nina
    Pfitzenmaier, Jesco
    Buse, Stephan
    Hohenfellner, Markus
    BJU INTERNATIONAL, 2008, 101 (10) : 1243 - 1246
12345